These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 28176788)
1. Decreased expression of STING predicts poor prognosis in patients with gastric cancer. Song S; Peng P; Tang Z; Zhao J; Wu W; Li H; Shao M; Li L; Yang C; Duan F; Zhang M; Zhang J; Wu H; Li C; Wang X; Wang H; Ruan Y; Gu J Sci Rep; 2017 Feb; 7():39858. PubMed ID: 28176788 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-143-3p, up-regulated in H. pylori-positive gastric cancer, suppresses tumor growth, migration and invasion by directly targeting AKT2. Wang F; Liu J; Zou Y; Jiao Y; Huang Y; Fan L; Li X; Yu H; He C; Wei W; Wang H; Sun G Oncotarget; 2017 Apr; 8(17):28711-28724. PubMed ID: 28404925 [TBL] [Abstract][Full Text] [Related]
3. Elevated FOXO6 expression correlates with progression and prognosis in gastric cancer. Wang JH; Tang HS; Li XS; Zhang XL; Yang XZ; Zeng LS; Ruan Q; Huang YH; Liu GJ; Wang J; Cui SZ Oncotarget; 2017 May; 8(19):31682-31691. PubMed ID: 28404958 [TBL] [Abstract][Full Text] [Related]
4. CXCL1 gene silencing inhibits HGC803 cell migration and invasion and acts as an independent prognostic factor for poor survival in gastric cancer. Wang L; Zhang C; Xu J; Wu H; Peng J; Cai S; He Y Mol Med Rep; 2016 Nov; 14(5):4673-4679. PubMed ID: 27748927 [TBL] [Abstract][Full Text] [Related]
5. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer. Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725 [TBL] [Abstract][Full Text] [Related]
6. Autophagy impairment by Helicobacter pylori-induced methylation silencing of MAP1LC3Av1 promotes gastric carcinogenesis. Muhammad JS; Nanjo S; Ando T; Yamashita S; Maekita T; Ushijima T; Tabuchi Y; Sugiyama T Int J Cancer; 2017 May; 140(10):2272-2283. PubMed ID: 28214334 [TBL] [Abstract][Full Text] [Related]
7. Elevated JMJD1A is a novel predictor for prognosis and a potential therapeutic target for gastric cancer. Yang H; Liu Z; Yuan C; Zhao Y; Wang L; Hu J; Xie D; Wang L; Chen D Int J Clin Exp Pathol; 2015; 8(9):11092-9. PubMed ID: 26617828 [TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori promotes angiogenesis depending on Wnt/beta-catenin-mediated vascular endothelial growth factor via the cyclooxygenase-2 pathway in gastric cancer. Liu N; Zhou N; Chai N; Liu X; Jiang H; Wu Q; Li Q BMC Cancer; 2016 May; 16():321. PubMed ID: 27198692 [TBL] [Abstract][Full Text] [Related]
9. Gastric cancer patients with Helicobacter pylori infection have a poor prognosis. Li G; Wang Z; Wang Z; Xu J; Cui J; Cai S; Zhan W; He Y J Surg Oncol; 2013 Dec; 108(7):421-6. PubMed ID: 24037736 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of decreased expression of RBM4 in human gastric cancer. Yong H; Zhu H; Zhang S; Zhao W; Wang W; Chen C; Ding G; Zhu L; Zhu Z; Liu H; Zhang Y; Wen J; Kang X; Zhu J; Feng Z; Liu B Sci Rep; 2016 Jun; 6():28222. PubMed ID: 27324405 [TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori promotes invasion and metastasis of gastric cancer cells through activation of AP-1 and up-regulation of CACUL1. Kong Y; Ma LQ; Bai PS; Da R; Sun H; Qi XG; Ma JQ; Zhao RM; Chen NZ; Nan KJ Int J Biochem Cell Biol; 2013 Nov; 45(11):2666-78. PubMed ID: 24004834 [TBL] [Abstract][Full Text] [Related]
12. Expression of Helios in gastric tumor cells predicts better survival in gastric cancer patients. Chen WM; Wu CS; Liu JL; Yeh CM; Tseng L; Huang HC; Chang PJ; Wu SF J Cancer Res Clin Oncol; 2016 Nov; 142(11):2375-82. PubMed ID: 27576507 [TBL] [Abstract][Full Text] [Related]
13. Targeting the STING pathway in tumor-associated macrophages regulates innate immune sensing of gastric cancer cells. Miao L; Qi J; Zhao Q; Wu QN; Wei DL; Wei XL; Liu J; Chen J; Zeng ZL; Ju HQ; Luo HY; Xu RH Theranostics; 2020; 10(2):498-515. PubMed ID: 31903134 [No Abstract] [Full Text] [Related]
14. Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer. He LJ; Xie D; Hu PJ; Liao YJ; Deng HX; Kung HF; Zhu SL World J Gastroenterol; 2015 Sep; 21(34):9916-26. PubMed ID: 26379396 [TBL] [Abstract][Full Text] [Related]
15. Upregulation of KPNβ1 in gastric cancer cell promotes tumor cell proliferation and predicts poor prognosis. Zhu J; Wang Y; Huang H; Yang Q; Cai J; Wang Q; Gu X; Xu P; Zhang S; Li M; Ding H; Yang L Tumour Biol; 2016 Jan; 37(1):661-72. PubMed ID: 26242264 [TBL] [Abstract][Full Text] [Related]
16. Proteomics-Based Identification and Analysis of Proteins Associated with Helicobacter pylori in Gastric Cancer. Zhou J; Wang W; Xie Y; Zhao Y; Chen X; Xu W; Wang Y; Guan Z PLoS One; 2016; 11(1):e0146521. PubMed ID: 26745502 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients. Li X; Cheung KF; Ma X; Tian L; Zhao J; Go MY; Shen B; Cheng AS; Ying J; Tao Q; Sung JJ; Kung HF; Yu J Oncogene; 2012 Jul; 31(29):3419-30. PubMed ID: 22105368 [TBL] [Abstract][Full Text] [Related]
18. Intestine-specific homeobox (ISX) induces intestinal metaplasia and cell proliferation to contribute to gastric carcinogenesis. Sue S; Shibata W; Kameta E; Sato T; Ishii Y; Kaneko H; Miwa H; Sasaki T; Tamura T; Kondo M; Maeda S J Gastroenterol; 2016 Oct; 51(10):949-60. PubMed ID: 26872890 [TBL] [Abstract][Full Text] [Related]
19. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer. Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of stromal cell-derived factor 1 expression in patients with gastric cancer after surgical resection. Wang X; Zhang H; He H; Shen Z; Tang Z; Xu J; Sun Y Cancer Sci; 2014 Nov; 105(11):1447-56. PubMed ID: 25220301 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]